1 – 30 of 30
- show: 250
- |
- sort: year (new to old)
- |
- Export
- 2021
- A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastoma (2021) THERANOSTICS. 11(16). p.7911-7947
- Assessment of the effect of therapy in a rat model of glioblastoma using [18F]FDG and [18F]FCho PET compared to contrast-enhanced MRI (2021) PLOS ONE. 16(3).
- 2019
- New fluoroethyl phenylalanine analogues as potential LAT1-targeting PET tracers for glioblastoma (2019) SCIENTIFIC REPORTS. 9.
- Technical feasibility of [18F]FET and [18F]FAZA PET guided radiotherapy in a F98 glioblastoma rat model (2019) RADIATION ONCOLOGY. 14.
- The path toward PET-guided radiation therapy for glioblastoma in laboratory animals : a mini review (2019) FRONTIERS IN MEDICINE. 6.
- 2018
- [18F]-FET and [18F]-FAZA PET guided irradiation of glioblastoma in rats (2018) European Molecular Imaging meeting, 13th, Abstracts.
- 2017
- 18F-FCho PET and MRI for the prediction of response in glioblastoma patients according to the RANO criteria (2017) NUCLEAR MEDICINE COMMUNICATIONS. 38(3). p.242-249
- In vivo DCE-MRI for the discrimination between glioblastoma and radiation necrosis in rats (2017) MOLECULAR IMAGING AND BIOLOGY. 19(6). p.857-866
- PET and MRI guided irradiation of a glioblastoma rat model using a micro-irradiator (2017) JOVE-JOURNAL OF VISUALIZED EXPERIMENTS.
- PET for therapy response assessment in glioblastoma (2017) Glioblastoma. p.175-195
- In vitro and in vivo evaluation of the LAT1 PET tracer 2-[18F]FELP in comparison to [18F]FET and [18F]FDG (2017) NEURO-ONCOLOGY. 19(suppl. 3). p.46-46
- In vitro characterization of the amino acid PET tracer 2-[18F]FELP and in vivo comparison to [18F]FET and [18F]FDG in a F98 glioblastoma rat model (2017) 18th Symposium of the Belgian Society of Nuclear Medicine, 5th to 7th May 2017, Ghent. p.1-1
- Assessment of therapy response and differentiation between tumor recurrence and therapy-related effects in high-grade glioma using PET and MRI (2017)
- 2016
- Kinetic modeling and graphical analysis of 18F-fluoromethylcholine (FCho), 18F-fluoroethyltyrosine (FET) and 18F-fluorodeoxyglucose (FDG) PET for the discrimination between high-grade glioma and radiation necrosis in rats (2016) PLOS ONE. 11(8).
- Evaluation of the LAT1 selective amino acid PET tracer 2-[18F]FELP in comparison to [18F]FET and [18F]FDG in a F98 glioblastoma rat model (2016) World Molecular Imaging Congress, Abstracts.
- 2015
- 18F-fluoromethylcholine (FCho), 18F-fluoroethyltyrosine (FET), and 18F-fluorodeoxyglucose (FDG) for the discrimination between high-grade glioma and radiation necrosis in rats: a PET study (2015) NUCLEAR MEDICINE AND BIOLOGY. 42(1). p.38-45
- 2014
- MRI-guided 3D conformal arc micro-irradiation of a F98 glioblastoma rat model using the Small Animal Radiation Research Platform (SARRP) (2014) JOURNAL OF NEURO-ONCOLOGY. 120(2). p.257-266
- 18F-fluoromethylcholine (FCho), 18F-fluoroethylthyrosine (FET), 18F-fluordeoxyglucose (FDG) PET for the discrimination between high-grade glioma (HGG) and radiation necrosis (RN): a µPET study (2014) JOURNAL OF NUCLEAR MEDICINE. 55(1).
- F-18 fluoromethylcholine (F-18 FCho) PET for the prediction of response according to the RANO criteria in glioblastoma patients (2014) World Molecular Imaging Congress, Abstracts.
- F-18 fluoromethylcholine (FCho), F-18 fluoroethyltyrosine (FET) and F-18 fluorodeoxyglucose (FDG) for the discrimination between high-grade glioma and radiation necrosis in rats: a PET study (2014) European Molecular Imaging Meeting, Abstracts.
- F-18 fluoromethylcholine (FCho), F-18 fluoroethyltyrosine (FET) and F-18 fluorodeoxyglucose (FDG) for the discrimination between tumor recurrence and radiation necrosis in high-grade glioma: a µPET study (2014) OncoPoint, 2nd Meeting, Abstracts.
- Molecular MRI in preclinical research (2014) OncoPoint, 2nd Meeting, Abstracts.
- Molecular MRI in preclinical research (2014) Knowledge for Growth, Abstracts. p.11-11
- Targeting radiation-induced neuroinflammation using ICAM-MPIO (2014) ISMRM BeNeLux Chapter, 6th Annual meeting, Abstracts.
- Targeting radiation-induced neuroinflammation using ICAM-MPIO (2014) European Molecular Imaging Meeting, Abstracts.
- Use of 18F-fluoromethylcholine PET in early treatment response assessment in glioblastoma patients (2014) NEURO-ONCOLOGY. 16(suppl. 2).
- 2013
- Structural and metabolic features of two different variants of multiple sclerosis : a PET/MRI study (2013) JOURNAL OF NEUROIMAGING. 23(3). p.431-436
- In vivo magnetic resonance imaging of acute radiation induced inflammation using ICAM1 targeted micron-sized particles of iron oxide (ICAM-MPIO) (2013) World Molecular Imaging Congress, Abstracts.
- MRI-guided 3D-conformal arc micro-irradiation of a F98 glioblastoma rat model using a small animal radiation research platform (2013) World Molecular Imaging Congress, Abstracts.
- 2012
- The optimal timing for imaging brain tumours and other brain lesions with 18F-labelled fluoromethylcholine: a dynamic positron emission tomography study (2012) NUCLEAR MEDICINE COMMUNICATIONS. 33(9). p.954-959